Skip to main content
Top
Published in: Clinical and Translational Oncology 10/2014

01-10-2014 | Research Article

Looking for complementary alternatives to CTCAE for skin toxicity in radiotherapy: quantitative determinations

Authors: A. González-Sanchís, A. Vicedo-González, L. Brualla-González, J. C. Gordo-Partearroyo, R. Iñigo-Valdenebro, J. Sánchez-Carazo, D. Granero-Cabañero, J. Roselló-Ferrando, J. López-Torrecilla

Published in: Clinical and Translational Oncology | Issue 10/2014

Login to get access

Abstract

Introduction

Radiotherapy (RT) is an essential part of the patient’s treatment diagnosed with cancer. Determination of the most common RT secondary effect, the cutaneous toxicity, is usually based on visual rating scales, like Common Terminology Criteria for Adverse Events with an inherent subjectivity. The aim of this work is to perform an objective method to evaluate the radiodermatitis using a non-invasive imaging technique based on laser Doppler flowmetry (LDF).

Materials and methods

A prospective study was performed analysing 1,824 measurements. A LDF was used to measure the cutaneous microcirculation in real time. A basal measurement was taken prior to radiotherapy treatment. To be able to observe the microcirculation changes related to the delivered dose, several sets of measurements were taken in the irradiated area along the RT treatment and in the contralateral non-irradiated area.

Results

A relative increase in blood flow at all measured points was found in the irradiated area. This relative increase in blood flow increases with the dose administered. In the non-irradiated contralateral area, the relative increase in blood flow is not significant and is independent of the dose administered. After treatment, a decrease in blood flow was detected with a trend towards returning to the baseline measurements.

Conclusions

LDF is an objective technique that assesses early radiodermatitis. This method is useful to develop strategies to prevent onset of radiation dermatitis in patients irradiated, such as the modification and individualization of fractionation parameters of the RT. This allows the reduction of radiation morbidities and maintains patient quality of life.
Literature
1.
go back to reference Bentzen SM, Dorr W, Anscher MS, Denham JW, Hauer-Jensen M, Marks LB, et al. Normal tissue effects: reporting and analysis. Semin Radiat Oncol. 2003;13:189–202.PubMedCrossRef Bentzen SM, Dorr W, Anscher MS, Denham JW, Hauer-Jensen M, Marks LB, et al. Normal tissue effects: reporting and analysis. Semin Radiat Oncol. 2003;13:189–202.PubMedCrossRef
2.
go back to reference Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31:1341–6.PubMedCrossRef Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31:1341–6.PubMedCrossRef
3.
go back to reference Cancer Therapy Evaluation Program (CTEP) of the National Cancer Institute (NCI). Common Terminology Criteria for Adverse Events (CTCAE): version 4.0. US Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Bethesda: Maryland; 2009. v4.02: 2009. Cancer Therapy Evaluation Program (CTEP) of the National Cancer Institute (NCI). Common Terminology Criteria for Adverse Events (CTCAE): version 4.0. US Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Bethesda: Maryland; 2009. v4.02: 2009.
4.
go back to reference Freedman GM, Anderson PR, Li J, Eisenberg DF, Hanlon AL, Wang L, et al. Intensity modulated radiation therapy (IMRT) decreases acute skin toxicity for women receiving radiation for breast cancer. Am J Clin Oncol. 2006;29:66–70.PubMedCrossRef Freedman GM, Anderson PR, Li J, Eisenberg DF, Hanlon AL, Wang L, et al. Intensity modulated radiation therapy (IMRT) decreases acute skin toxicity for women receiving radiation for breast cancer. Am J Clin Oncol. 2006;29:66–70.PubMedCrossRef
5.
go back to reference Formenti S, Gidea-Addeo D, Goldberg J, Roses D, Guth A, Rosenstein B, et al. Phase I–II trial of prone accelerated intensity modulated radiation therapy to the breast to optimally spare normal tissue. J Clin Oncol. 2007;25:2236–42.PubMedCrossRef Formenti S, Gidea-Addeo D, Goldberg J, Roses D, Guth A, Rosenstein B, et al. Phase I–II trial of prone accelerated intensity modulated radiation therapy to the breast to optimally spare normal tissue. J Clin Oncol. 2007;25:2236–42.PubMedCrossRef
6.
go back to reference Pommier P, Gomez F, Sunyach MP, D’Hombres A, Carrie C, Montbarbon X. Phase III randomized trial of calendula officinalis compared with trolamine for the prevention of acute dermatitis during irradiation for breast cancer. J Clin Oncol. 2004;22:1447–53.PubMedCrossRef Pommier P, Gomez F, Sunyach MP, D’Hombres A, Carrie C, Montbarbon X. Phase III randomized trial of calendula officinalis compared with trolamine for the prevention of acute dermatitis during irradiation for breast cancer. J Clin Oncol. 2004;22:1447–53.PubMedCrossRef
7.
go back to reference Mukesh M, Harris E, Jena R, Coles Ch. Relationship between irradiated breast volume and late normal tissue complications. A systematic review. Radiother Oncol. 2012;104:1–10.PubMedCrossRef Mukesh M, Harris E, Jena R, Coles Ch. Relationship between irradiated breast volume and late normal tissue complications. A systematic review. Radiother Oncol. 2012;104:1–10.PubMedCrossRef
8.
go back to reference Pigno J, Olivotto I, Rakovitch E, Gardner S, Sixel K, Beckham W, et al. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol. 2008;26:2085–92.CrossRef Pigno J, Olivotto I, Rakovitch E, Gardner S, Sixel K, Beckham W, et al. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol. 2008;26:2085–92.CrossRef
9.
go back to reference Bonner RF, Clem TR, Bowen PD. Laser Doppler continuous real-time monitor of pulsatile and mean blood flow in tissue microcirculation. In: Chen SH, Chu B, Nossal R, editors. Scattering techniques applied to supramolecular and non-equilibrium systems. New York: Plenum Press; 1981. p. 685–701.CrossRef Bonner RF, Clem TR, Bowen PD. Laser Doppler continuous real-time monitor of pulsatile and mean blood flow in tissue microcirculation. In: Chen SH, Chu B, Nossal R, editors. Scattering techniques applied to supramolecular and non-equilibrium systems. New York: Plenum Press; 1981. p. 685–701.CrossRef
10.
go back to reference Bonner R, Nossal R. Model for laser Doppler measurements of blood flow in tissue. Appl Opt. 1981;20:2097–107.PubMedCrossRef Bonner R, Nossal R. Model for laser Doppler measurements of blood flow in tissue. Appl Opt. 1981;20:2097–107.PubMedCrossRef
11.
go back to reference Saumet JL, Dittmar A, Leftheriotis G. Non-invasive measurement of skin blood flow: comparison between plethysmography, laser Doppler flowmeter and heat thermal clearance method. Int J Microcirc Clin Exp. 1986;5:73–83.PubMed Saumet JL, Dittmar A, Leftheriotis G. Non-invasive measurement of skin blood flow: comparison between plethysmography, laser Doppler flowmeter and heat thermal clearance method. Int J Microcirc Clin Exp. 1986;5:73–83.PubMed
12.
go back to reference Fagrell B. Advances in microcirculation network evaluation: an update. Int J Microcirc Clin Exp. 1995;15(Suppl 1):34–40.PubMedCrossRef Fagrell B. Advances in microcirculation network evaluation: an update. Int J Microcirc Clin Exp. 1995;15(Suppl 1):34–40.PubMedCrossRef
13.
go back to reference Chufa HE, Cherry GW. Blood flow in patients with leg ulcers. In: Mani R, Falanga V, Shearman CP, Sandeman D, editors. Chronic wound healing. Clinical measurement and basic science. London: W.B. Saunders; 2000. Chufa HE, Cherry GW. Blood flow in patients with leg ulcers. In: Mani R, Falanga V, Shearman CP, Sandeman D, editors. Chronic wound healing. Clinical measurement and basic science. London: W.B. Saunders; 2000.
14.
go back to reference Romanelli M, Falanga V. Measurement of transcutaneous oxygen tension in chronic wounds. In: Mani R, Falanga V, Shearman CP, Sandeman D, editors. Chronic wound healing. Clinical measurement and basic science. London: W.B. Saunders; 2000. Romanelli M, Falanga V. Measurement of transcutaneous oxygen tension in chronic wounds. In: Mani R, Falanga V, Shearman CP, Sandeman D, editors. Chronic wound healing. Clinical measurement and basic science. London: W.B. Saunders; 2000.
15.
go back to reference Bland JM, Altman DG. Statistical methods for assessing agreement between measurement. Biochim Clin. 1987;11:399–404. Bland JM, Altman DG. Statistical methods for assessing agreement between measurement. Biochim Clin. 1987;11:399–404.
16.
go back to reference Evaluation of measurement data—guide to the expression of uncertainty in measurement. JCGM. 2008;100. Evaluation of measurement data—guide to the expression of uncertainty in measurement. JCGM. 2008;100.
17.
go back to reference Schnur JB, Love B, Scheckner BL, Green S, Wernicke AG, Montgomery GH. A systematic review of patient-rated measures of radiodermatitis in breast cancer radiotherapy. Am J Clin Oncol. 2011;34:529–36.PubMedPubMedCentral Schnur JB, Love B, Scheckner BL, Green S, Wernicke AG, Montgomery GH. A systematic review of patient-rated measures of radiodermatitis in breast cancer radiotherapy. Am J Clin Oncol. 2011;34:529–36.PubMedPubMedCentral
18.
go back to reference Feight D, Baney T, Bruce S, McQuestion M. Evidence-based interventions for radiation dermatitis. Clin J Oncol Nurs. 2011;15(5):481–92.PubMedCrossRef Feight D, Baney T, Bruce S, McQuestion M. Evidence-based interventions for radiation dermatitis. Clin J Oncol Nurs. 2011;15(5):481–92.PubMedCrossRef
19.
go back to reference Archambeau JO, Pezner R, Wasserman T. Pathophysiology of irradiated skin and breast. Int J Radiat Oncol Biol Phys. 1995;31:1171–85.PubMedCrossRef Archambeau JO, Pezner R, Wasserman T. Pathophysiology of irradiated skin and breast. Int J Radiat Oncol Biol Phys. 1995;31:1171–85.PubMedCrossRef
20.
go back to reference Chren MM, Lasek RJ, Sahay AP, Sands L. Measurement properties of Skindex-16: a brief quality-of-life measure for patients with skin diseases. J Cutan Med Surg. 2001;5(2):105–10.PubMedCrossRef Chren MM, Lasek RJ, Sahay AP, Sands L. Measurement properties of Skindex-16: a brief quality-of-life measure for patients with skin diseases. J Cutan Med Surg. 2001;5(2):105–10.PubMedCrossRef
21.
go back to reference Atherton PJ, Burger KN, Loprinzi CL, Neben Wittich MA, Miller RC, Jatoi A, et al. Using the Skindex-16 and Common Terminology Criteria for Adverse Events to assess rash symptoms: results of a pooled analysis (N0993). Support Care Cancer. 2012;20(8):1729–35.PubMedCrossRefPubMedCentral Atherton PJ, Burger KN, Loprinzi CL, Neben Wittich MA, Miller RC, Jatoi A, et al. Using the Skindex-16 and Common Terminology Criteria for Adverse Events to assess rash symptoms: results of a pooled analysis (N0993). Support Care Cancer. 2012;20(8):1729–35.PubMedCrossRefPubMedCentral
22.
go back to reference Lim CC, Devi MK, Ang E. Anxiety in women with breast cancer undergoing treatment: a systematic review. Int J Evid Based Healthc. 2011;9(3):215–35.PubMed Lim CC, Devi MK, Ang E. Anxiety in women with breast cancer undergoing treatment: a systematic review. Int J Evid Based Healthc. 2011;9(3):215–35.PubMed
23.
go back to reference Bostrom A, Lindman H, Swartling C, Berne B, Bergh J. Potent corticosteroid cream (mometasone furoate) significantly reduces acute radiation dermatitis: results from a double-blind, randomized study. Radiother Oncol. 2001;59:257–65.PubMedCrossRef Bostrom A, Lindman H, Swartling C, Berne B, Bergh J. Potent corticosteroid cream (mometasone furoate) significantly reduces acute radiation dermatitis: results from a double-blind, randomized study. Radiother Oncol. 2001;59:257–65.PubMedCrossRef
24.
go back to reference Dornfeld K, Gessert CE, Renier CM, McNaney DD, Urias RE, Knowles DM, et al. Differences in breast tissue oxygenation following radiotherapy. Radiother Oncol. 2011;100:289–92.PubMedCrossRef Dornfeld K, Gessert CE, Renier CM, McNaney DD, Urias RE, Knowles DM, et al. Differences in breast tissue oxygenation following radiotherapy. Radiother Oncol. 2011;100:289–92.PubMedCrossRef
Metadata
Title
Looking for complementary alternatives to CTCAE for skin toxicity in radiotherapy: quantitative determinations
Authors
A. González-Sanchís
A. Vicedo-González
L. Brualla-González
J. C. Gordo-Partearroyo
R. Iñigo-Valdenebro
J. Sánchez-Carazo
D. Granero-Cabañero
J. Roselló-Ferrando
J. López-Torrecilla
Publication date
01-10-2014
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 10/2014
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-014-1163-0

Other articles of this Issue 10/2014

Clinical and Translational Oncology 10/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine